Cohen C - Search Results

1

Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study.

Nassar A, Radhakrishnan A, Cabrero IA, Cotsonis GA, Cohen C. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):433-41. doi: 10.1097/PAI.0b013e3181dddb20. Appl Immunohistochem Mol Morphol. 2010. PMID: 20485156

2

Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.

Nassar A, Amin MB, Sexton DG, Cohen C. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):252-5. doi: 10.1097/00129039-200509000-00007. Appl Immunohistochem Mol Morphol. 2005. PMID: 16082251

3

COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome.

Nassar A, Radhakrishnan A, Cabrero IA, Cotsonis G, Cohen C. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):255-9. doi: 10.1097/01.pai.0000213130.63417.b3. Appl Immunohistochem Mol Morphol. 2007. PMID: 17721268

4

Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.

Nassar A, Lawson D, Cotsonis G, Cohen C. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):113-20. doi: 10.1097/PAI.0b013e318032ea73. Appl Immunohistochem Mol Morphol. 2008. PMID: 18227733

5

Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.

Nassar A, Sexton D, Cotsonis G, Cohen C. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2008 May;16(3):221-6. doi: 10.1097/PAI.0b013e3180c317bc. Appl Immunohistochem Mol Morphol. 2008. PMID: 18301249

6

A new immunohistochemical ER/PR image analysis system: a multisite performance study.

Nassar A, Cohen C, Agersborg SS, Zhou W, Lynch KA, Heyman ER, Olson A, Lange H, Siddiqui MT. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2011 May;19(3):195-202. doi: 10.1097/PAI.0b013e3181fe53cb. Appl Immunohistochem Mol Morphol. 2011. PMID: 21217524

7

Image cytometric validation of breast carcinoma markers (ER, HER2 and MIB-1) using tissue microarrays: rabbit monoclonal vs. FDA-approved antibodies.

Nassar A, Norton CM, Lawson D, Cohen C. Nassar A, et al. Among authors: cohen c. Anal Quant Cytol Histol. 2010 Aug;32(4):192-200. Anal Quant Cytol Histol. 2010. PMID: 21434519

8

Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.

Nassar A, Cohen C, Albitar M, Agersborg SS, Zhou W, Lynch KA, Heyman ER, Lange H, Siddiqui MT. Nassar A, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2011 May;19(3):212-7. doi: 10.1097/PAI.0b013e3181f5e84d. Appl Immunohistochem Mol Morphol. 2011. PMID: 21475038

9

Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.

Nassar A, Sussman ZM, Lawson D, Cohen C. Nassar A, et al. Among authors: cohen c. Breast J. 2012 Sep;18(5):399-405. doi: 10.1111/j.1524-4741.2012.01279.x. Epub 2012 Aug 10. Breast J. 2012. PMID: 22882580

10

Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance.

Garcia EJ, Lawson D, Cotsonis G, Cohen C. Garcia EJ, et al. Among authors: cohen c. Appl Immunohistochem Mol Morphol. 2002 Sep;10(3):210-7. doi: 10.1097/00129039-200209000-00004. Appl Immunohistochem Mol Morphol. 2002. PMID: 12373145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,403 results

Search Page

Filters